Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Lafon presents piperazinone-based antithrombotic agents

Feb. 22, 2000

AstraZeneca portfolio includes new series of P2T antagonists

Feb. 18, 2000

Stroke news: DuPont gpIIb/IIIa antagonist shows promise in ischemic stroke

Feb. 16, 2000

Anti-gpIIb/IIIa MAb fragment proves effective and safe in rat model of embolic stroke

Feb. 16, 2000

FDA extends decision date for Novastan NDA to Feburary 18

Feb. 15, 2000

UroGen cleared to begin phase I human clinical trial of gene therapy for hemophilia A

Feb. 14, 2000

Sibrafiban no better than aspirin in final analysis of SYMPHONY study

Feb. 11, 2000

German investigators discover new anticoagulant compounds

Feb. 10, 2000

Integrilin stent study halted early due to positive results

Feb. 10, 2000

Long-term expression of factor VIII gene achieved in mice

Feb. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...